title: Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans.
authors: Department of Dermatology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
authors: Delphine
authors: D
authors: Kerob
authors: Florence
authors: F
authors: Pedeutour
authors: Christophe
authors: C
authors: Leboeuf
authors: Olivier
authors: O
authors: Verola
authors: Eric
authors: E
authors: de Kerviler
authors: Jean Marie
authors: JM
authors: Servant
authors: Farid
authors: F
authors: Sarandi
authors: Guilhem
authors: G
authors: Bousquet
authors: Isabelle
authors: I
authors: Madelaine-Chambrin
authors: Christelle
authors: C
authors: Pruvost
authors: Fabien
authors: F
authors: Calvo
authors: Anne
authors: A
authors: Janin
authors: Celeste
authors: C
authors: Lebbe
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D003131:Combined Modality Therapy; D020732:Cytogenetic Analysis; D018223:Dermatofibrosarcoma / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D010879:Piperazines / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011743:Pyrimidines / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate